Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04519723 · ClinicalTrials.gov registry record · NA
Laser 360iQ: Optimal Light-laser Combination Therapy
A NA study, sponsored by Alma Lasers.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04519723 is a NA study that has completed, run by Alma Lasers. The registered enrollment target is 8 participants.
The verdict
NCT04519723, a NA study, has completed, sponsored by Alma Lasers.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
To assess the safety and efficacy of light-laser combination therapy for the improvement of skin color, tone, texture and laxity
Interventions
- DEVICE Assess the safety and efficacy of light-laser therapy using the Harmony XL and Dye-VL (500-600nm), Q-Switched 1064nm, Er:YAG 2940nm modules in combination .
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04519723
The ClinicalTrials.gov registry entry for NCT04519723 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alma Lasers, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Assess the safety and efficacy of light-laser therapy using the Harmony XL and Dye-VL (500-600nm), Q-Switched 1064nm, Er:YAG 2940nm modules in combination . is the first listed.
NCT04519723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04519723 about?
NCT04519723 is a clinical study titled "Laser 360iQ: Optimal Light-laser Combination Therapy". To assess the safety and efficacy of light-laser combination therapy for the improvement of skin color, tone, texture and laxity
What is the current status of trial NCT04519723?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2013-02. Estimated completion is 2014-06.
What interventions are being tested in trial NCT04519723?
The interventions under investigation include: Assess the safety and efficacy of light-laser therapy using the Harmony XL and Dye-VL (500-600nm), Q-Switched 1064nm, Er:YAG 2940nm modules in combination . (DEVICE).
Who is sponsoring clinical trial NCT04519723?
This trial is sponsored by Alma Lasers, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.